A Study of Roxadustat for the Treatment of Anemia in Participants With Chronic Kidney Disease and Not Receiving Dialysis
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 922 participants.
Also called NCT01750190
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 922 participants
- Registry
-
NCT01750190
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States, Argentina, Australia, Chile, Colombia, Hong Kong SAR China, Malaysia, Mexico, New Zealand, Peru, Philippines, Puerto Rico, Singapore, South Korea, Taiwan, Thailand
- Registry status
- Completed
Technical summary
Registry record NCT01750190. Randomized; quadruple masking; primary purpose treatment. Start 2012-11-05 (actual); primary completion 2018-09-24 (actual). Results posted on 2021-10-01.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of Roxadustat for the Treatment of Anemia in Participants With Chronic Kidney Disease and Not Receiving Dialysis
- Condition
- CKD Anemia
- Intervention (Drug)
- Roxadustat
- Intervention (Drug)
- Placebo
- Lead sponsor
- Kyntra Bio
- Collaborator
- Astellas Pharma Europe B.V.
- Collaborator
- AstraZeneca
Record details
- Record id
cardio:ct-nct01750190- Content hash
905c5c6701949c0706ff906f75db4bec6ddd939b9964e38525677f8f5e75f350